A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

This study is currently recruiting participants.
Verified April 2014 by Tesaro, Inc.
European Network of Gynaecological Oncological Trial Groups (ENGOT)
FORCE Facing our Risk of Cancer Empowered
Information provided by (Responsible Party):
Tesaro, Inc.
ClinicalTrials.gov Identifier:
First received: April 11, 2013
Last updated: April 2, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2016
  Estimated Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)